AI
AMGEN INC
AMGN· Health Care· BiotechnologyS&P 500
Close · 12/11/2026
467.06
1D
-0.22%52-week range
312.39 – 483.99
Volume
28,27,600.00
Price history
AMGN
14/10/2026 to 12/11/2026
O 471.86 H 474.00 L 466.92
1W+1.47%
1M+9.61%
3M+12.49%
6M+38.91%
1Y+38.00%
3Y+72.28%
5Y+117.31%
MAX+118.51%
Fundamentals
as of 12/11/2026- Market cap
- $252.64B
- Shares out
- 540.91M
- P/E (trailing)
- 26.90
- P/E (forward)
- 18.59
- EPS (trailing)
- 17.36
- Dividend yield
- 2.13%
- Beta
- 0.42
- Profit margin
- 24.14%
- P/B
- 17.60
- Return on equity
- 65.43%
SEC financial statements
68 quarterly and 19 annual periods through 30/09/2026.
Details
- Ticker
- AMGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
23 filers · 2 on watchlist · 37 buys · 28 sells · ?: 2 · D: 27 · R: 36
- 22/09/2026David J. TaylorBuyAmgen Inc. - Common Stock$1,001–$15,000
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 26/08/2026David J. TaylorSellAmgen Inc. - Common Stock$1,001–$15,000
- 12/08/2026Sheldon WhitehouseSell+Amgen Inc. - Common Stock$1,001–$15,000
- 15/04/2025Thomas H TubervilleWSellAmgen Inc$15,001–$50,000
- 27/03/2026Alan ArmstrongSellAmgen Inc. - Common Stock$15,001–$50,000
- 05/06/2026David J. TaylorBuyAmgen Inc. - Common Stock$1,001–$15,000
- 17/04/2026Maria Elvira SalazarSellAmgen Inc. - Common Stock$15,001–$50,000